Less-Invasive Test May Increase Colorectal Cancer Screening

Because nobody enjoys a colonoscopy, a noninvasive test is getting a closer look as a more pleasant alternative for screening workers who may be at higher risk of colorectal cancer due to chemical exposures. The fecal immunochemical test, or FIT, which checks a patient’s stool sample for signs of cancer, was spotlighted last week by Concentra in an article on the occupational medicine company’s website. FIT may be of particular interest in manufacturing and other industries where workers are exposed to chemicals, Concentra noted. “In recent years, researchers have begun to...